,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,180,1,1,,85661,12699,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Adenocarcinoma 755 (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
1,188,1,1,,85661,12699,Unspecified,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Nontumored Animals (Toxicity Test) in CD2F1 (CDF1) mice,Other,,
2,192,1,1,,85661,12699,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
3,194,1,1,,85661,12699,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
4,196,1,1,,85661,12699,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intracerebral) in B6D2F1 (BDF1) mice,Other,,
5,200,1,1,,85661,12699,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6C3F1 mice,Other,,
6,204,1,1,,85661,12699,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P288 Lymphocytic Leukemia resistant to methotrexate; NSC 740 (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
7,206,1,1,,85661,12699,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  HT29;CX-1 Human Adenocarcinoma (MER+) (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
8,212,1,1,,85661,12699,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Colon Carcinoma 38 (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
9,220,1,1,,85661,12699,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Mammary Adenocarcinoma CD8F1 (subcutaneous) in CD8F1,Other,,
10,222,1,1,,85661,12699,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Ependymoblastoma (intracerebral) in C57BL/6 mice,Other,,
11,226,1,1,,85661,12699,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Ependymoblastoma (intracerebral) in B6C3F1 mice,Other,,
12,228,1,1,,85661,12699,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Friend Virus Leukemia (Solid) (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
13,234,1,1,,85661,12699,Inconclusive,,,,,"NCI In Vivo Anticancer Drug Screen. Data for tumor model  Cystadenocarcinoma, Liver (No. 1) (Hamster) (subcutaneous) in C3AKF1 (CHKRF1) mice",Other,,
14,236,1,1,,85661,12699,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  AK4 Lymphoid Leukemia (intraperitoneal) in C3AKF1 (CHKRF1) mice,Other,,
15,242,1,1,,85661,12699,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lymphoma 8 (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
16,248,1,1,,85661,12699,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
17,250,1,1,,85661,12699,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
18,252,1,1,,85661,12699,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intracerebral) in B6D2F1 (BDF1) mice,Other,,
19,256,1,1,,85661,12699,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
20,260,1,1,,85661,12699,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intracerebral) in CD2F1 (CDF1) mice,Other,,
21,264,1,1,,85661,12699,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Lung LX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
22,266,1,1,,85661,12699,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Lung LX-1 Xenograft (intrarenal inoculation) in NU/NU BALB/C (nude) mice,Other,,
23,270,1,1,,85661,12699,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
24,272,1,1,,85661,12699,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (intramuscular) in B6D2F1 (BDF1) mice,Other,,
25,276,1,1,,85661,12699,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (intravenous) in B6C3F1 mice,Other,,
26,284,1,1,,85661,12699,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia resistant to Methotrexate; NSC 740 (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
27,290,1,1,,85661,12699,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P1798 Lymphosarcoma (subcutaneous) in unknown mice,Other,,
28,296,1,1,,85661,12699,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Mammary Carcinoma MX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
29,298,1,1,,85661,12699,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Mammary Carcinoma MX-1 Xenograft (intrarenal inoculation) in NU/NU BALB/C (nude) mice,Other,,
30,306,1,1,,85661,12699,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia resistant to Methyl-GAG; NSC 32946 (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
31,310,1,1,,85661,12699,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Osteogenic Sarcoma HE 10734 (subcutaneous) in C3AKF1 (CHKRF1) mice,Other,,
32,328,1,1,,85661,12699,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
33,330,1,1,,85661,12699,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
34,338,1,1,,85661,12699,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia resistant to A Terephthalanilide; NSC 38280 (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
35,342,1,1,,85661,12699,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Sarcoma 180 (subcutaneous) in Swiss mice,Other,,
36,344,1,1,,85661,12699,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lieberman Plasma Cell No. 1 (LPC-1) (intraperitoneal) in unknown mice,Other,,
37,1189,1,5,,48414177,12699,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results,Other,,
38,1190,1,3,,48414177,12699,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Dog & Primates Bioassay Results,Other,,
39,1194,1,3,,48414177,12699,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity,Other,,
40,1199,1,3,,48414177,12699,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results,Other,,
41,1205,1,4,,48414177,12699,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results,Other,,
42,1208,1,3,,48414177,12699,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results,Other,,
43,23443,3,3,,103213072,12699,Unspecified,,,,,Partition coefficient (logP),Other,3882967.0,
44,23772,6,1,,103213072,12699,Unspecified,,,,,Half life was measured at pH 7,Other,3336023.0,
45,26180,3,3,,103213072,12699,Unspecified,,,,,Half-life in plasma by using UV method,Other,7205887.0,
46,134111,3,3,,103213072,12699,Unspecified,,,,,"Mean life extension in mice bearing Trypanosoma rhodesiense, after ip administration at a dose of 0.2 mmol/kg",Other,2299638.0,
47,134248,3,3,,103213072,12699,Unspecified,,,,,"Mean life extension in mice bearing Trypanosoma rhodesiense, after ip administration at 0.4 mmol/kg dose",Other,2299638.0,
48,651631,4,1,,144213167,12699,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
49,651632,4,1,,144213167,12699,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
50,651633,4,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
51,651634,4,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
52,720516,2,1,,144213167,12699,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
53,720552,2,1,,144213167,12699,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
54,720634,2,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
55,720635,2,1,,144213167,12699,Inconclusive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
56,720637,2,1,,144213167,12699,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
57,720674,2,2,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
58,720675,2,2,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
59,720678,2,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
60,720679,2,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
61,720680,2,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
62,720681,2,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
63,720682,2,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
64,720683,2,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
65,720684,2,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
66,720685,2,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
67,720686,2,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
68,720687,2,2,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
69,720691,4,1,,144213167,12699,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
70,720692,3,1,,144213167,12699,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
71,720693,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
72,720719,2,1,,144213167,12699,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
73,720725,2,1,,144213167,12699,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
74,743012,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
75,743014,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
76,743015,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
77,743033,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
78,743035,2,1,,144213167,12699,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
79,743036,2,1,,144213167,12699,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
80,743040,3,1,,144213167,12699,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
81,743041,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
82,743042,3,1,,144213167,12699,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
83,743053,2,1,,144213167,12699,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
84,743054,2,1,,144213167,12699,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
85,743063,2,1,,144213167,12699,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
86,743064,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
87,743065,3,1,,144213167,12699,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
88,743066,3,1,,144213167,12699,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
89,743067,2,1,,144213167,12699,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
90,743069,2,1,,144213167,12699,Inactive,348019627.0,2099.0,4.8972,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
91,743074,2,1,,144213167,12699,Inconclusive,,,4.8972,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
92,743075,2,1,,144213167,12699,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
93,743077,2,1,,144213167,12699,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
94,743078,2,1,,144213167,12699,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
95,743079,3,1,,144213167,12699,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
96,743080,3,1,,144213167,12699,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
97,743081,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
98,743083,3,1,,144213167,12699,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
99,743084,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
100,743085,3,1,,144213167,12699,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
101,743086,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
102,743091,2,1,,144213167,12699,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
103,743094,3,1,,144213167,12699,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
104,743122,2,1,,144213167,12699,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
105,743139,2,1,,144213167,12699,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
106,743140,2,1,,144213167,12699,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
107,743191,3,1,,144213167,12699,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
108,743194,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
109,743199,2,1,,144213167,12699,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
110,743202,4,1,,144213167,12699,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
111,743203,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
112,743209,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
113,743210,4,1,,144213167,12699,Inconclusive,4504517.0,3315.0,61.6524,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
114,743211,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
115,743212,3,1,,144213167,12699,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
116,743213,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
117,743215,3,1,,144213167,12699,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
118,743217,3,1,,144213167,12699,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
119,743218,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
120,743219,3,1,,144213167,12699,Inactive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
121,743220,3,1,,144213167,12699,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
122,743221,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
123,743222,3,1,,144213167,12699,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
124,743223,3,1,,144213167,12699,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
125,743224,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
126,743225,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
127,743226,2,1,,144213167,12699,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
128,743227,2,1,,144213167,12699,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
129,743228,3,1,,144213167,12699,Active,4504517.0,3315.0,52.879,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
130,743239,2,1,,144213167,12699,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
131,743240,2,1,,144213167,12699,Inconclusive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
132,743241,2,1,,144213167,12699,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
133,743242,2,1,,144213167,12699,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
134,831258,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 716/2,Other,,
135,831259,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 716/2,Other,,
136,831260,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 716/2,Other,,
137,831261,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 716/2,Other,,
138,831262,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 716/2,Other,,
139,831263,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 716/2,Other,,
140,831264,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 716/2,Other,,
141,831265,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 716/2,Other,,
142,831266,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 716/2,Other,,
143,831267,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 716/2,Other,,
144,831268,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 716/2,Other,,
145,831269,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 716/2,Other,,
146,831270,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 716/2,Other,,
147,831271,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 716/2,Other,,
148,831272,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 716/2,Other,,
149,831273,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 716/2,Other,,
150,831274,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 716/3,Other,,
151,831275,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 716/3,Other,,
152,831276,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 716/3,Other,,
153,831277,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 716/3,Other,,
154,831278,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 716/3,Other,,
155,831279,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 716/3,Other,,
156,834082,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 716/3,Other,,
157,834083,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 716/3,Other,,
158,834084,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 716/3,Other,,
159,834085,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 716/3,Other,,
160,834086,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 716/3,Other,,
161,834087,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 716/3,Other,,
162,834088,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 716/3,Other,,
163,834089,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 716/3,Other,,
164,834090,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 716/3,Other,,
165,834091,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 716/3,Other,,
166,834092,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 716/4,Other,,
167,834093,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 716/4,Other,,
168,834094,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 716/4,Other,,
169,834095,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 716/4,Other,,
170,834096,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 716/4,Other,,
171,834097,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 716/4,Other,,
172,834098,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 716/4,Other,,
173,834099,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 716/4,Other,,
174,834100,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 716/4,Other,,
175,834101,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 716/4,Other,,
176,834102,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 716/4,Other,,
177,834103,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 716/4,Other,,
178,834104,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 716/4,Other,,
179,834105,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 716/4,Other,,
180,834106,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 716/4,Other,,
181,834107,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 716/4,Other,,
182,910515,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 716/2,Other,,
183,910516,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 716/2,Other,,
184,910517,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 716/2,Other,,
185,910929,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 716/2,Other,,
186,910930,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 716/2,Other,,
187,910931,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 716/2,Other,,
188,910932,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 716/2,Other,,
189,910933,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 716/2,Other,,
190,910934,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 716/2,Other,,
191,910935,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 716/2,Other,,
192,910936,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 716/2,Other,,
193,910937,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 716/2,Other,,
194,910938,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 716/2,Other,,
195,910939,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 716/2,Other,,
196,910940,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 716/2,Other,,
197,910941,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 716/2,Other,,
198,910942,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 716/2,Other,,
199,910943,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 716/2,Other,,
200,910944,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 716/2,Other,,
201,910945,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 716/3,Other,,
202,910946,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 716/3,Other,,
203,910947,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 716/3,Other,,
204,910948,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 716/3,Other,,
205,910949,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 716/3,Other,,
206,912379,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 716/3,Other,,
207,912380,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 716/3,Other,,
208,912381,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 716/3,Other,,
209,912382,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 716/3,Other,,
210,912383,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 716/3,Other,,
211,912384,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 716/3,Other,,
212,912385,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 716/3,Other,,
213,912386,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 716/3,Other,,
214,912387,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 716/3,Other,,
215,912388,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 716/3,Other,,
216,912389,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 716/3,Other,,
217,912390,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 716/3,Other,,
218,912391,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 716/3,Other,,
219,912392,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 716/3,Other,,
220,912393,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 716/4,Other,,
221,912394,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 716/4,Other,,
222,912792,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 716/4,Other,,
223,912793,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 716/4,Other,,
224,912794,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 716/4,Other,,
225,912795,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 716/4,Other,,
226,912796,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 716/4,Other,,
227,912797,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 716/4,Other,,
228,912798,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 716/4,Other,,
229,912799,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 716/4,Other,,
230,912800,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 716/4,Other,,
231,912801,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 716/4,Other,,
232,912802,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 716/4,Other,,
233,912803,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 716/4,Other,,
234,912804,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 716/4,Other,,
235,912805,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 716/4,Other,,
236,912806,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 716/4,Other,,
237,912807,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 716/4,Other,,
238,912808,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 716/4,Other,,
239,1048812,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 716/2,Other,,
240,1048813,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 716/2,Other,,
241,1048814,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 716/2,Other,,
242,1048815,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 716/2,Other,,
243,1048816,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: intraperitoneal injection | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 716/2,Other,,
244,1048817,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 716/3,Other,,
245,1048818,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 716/3,Other,,
246,1048819,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 716/3,Other,,
247,1048820,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 716/3,Other,,
248,1048821,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: intraperitoneal injection | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 716/3,Other,,
249,1048822,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 716/4,Other,,
250,1048823,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 716/4,Other,,
251,1048824,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 716/4,Other,,
252,1048825,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 716/4,Other,,
253,1048826,1,2,,103213072,12699,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: intraperitoneal injection | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 716/4,Other,,
254,1154293,1,1,,103213072,12699,Unspecified,,,100.0,IC50,Cytotoxicity against human HeLaS3 cells assessed as cell viability after 24 to 72 hrs by MTT assay,Confirmatory,24863982.0,
255,1159509,1,1,,144213167,12699,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
256,1159515,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
257,1159516,1,1,,144213167,12699,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
258,1159517,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
259,1159518,1,1,,144213167,12699,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
260,1159519,1,1,,144213167,12699,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
261,1159520,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
262,1159521,1,1,,144213167,12699,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
263,1159523,1,1,,144213167,12699,Inactive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
264,1159525,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
265,1159526,1,1,,144213167,12699,Inconclusive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
266,1159527,1,1,,144213167,12699,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
267,1159528,1,1,,144213167,12699,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
268,1159529,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
269,1159531,1,1,,144213167,12699,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
270,1159551,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
271,1159552,1,1,,144213167,12699,Inactive,325495463.0,5914.0,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
272,1159553,2,1,,144213167,12699,Inconclusive,325495463.0,5914.0,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
273,1159555,1,1,,144213167,12699,Inconclusive,325495463.0,5914.0,68.5896,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
274,1224834,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
275,1224835,1,1,,144213167,12699,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
276,1224836,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
277,1224837,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
278,1224838,1,1,,144213167,12699,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
279,1224839,1,1,,144213167,12699,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
280,1224840,3,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
281,1224841,3,1,,144213167,12699,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
282,1224842,3,1,,144213167,12699,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
283,1224843,1,1,,144213167,12699,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
284,1224844,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
285,1224845,1,1,,144213167,12699,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
286,1224846,1,1,,144213167,12699,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
287,1224847,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
288,1224848,3,1,,144213167,12699,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
289,1224849,3,1,,144213167,12699,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
290,1224867,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
291,1224868,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
292,1224869,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
293,1224870,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
294,1224871,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
295,1224872,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
296,1224873,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
297,1224874,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
298,1224875,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
299,1224876,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
300,1224877,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
301,1224878,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
302,1224879,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
303,1224880,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
304,1224881,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
305,1224882,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
306,1224883,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
307,1224884,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
308,1224885,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
309,1224886,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
310,1224887,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
311,1224888,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
312,1224889,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
313,1224890,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
314,1224892,1,1,,144213167,12699,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
315,1224893,1,1,,144213167,12699,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
316,1224894,1,1,,144213167,12699,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
317,1224895,1,1,,144213167,12699,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
318,1224896,1,1,,144213167,12699,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
319,1259241,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
320,1259242,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
321,1259243,1,1,,144213167,12699,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
322,1259244,1,1,,144213167,12699,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
323,1259247,1,1,,144213167,12699,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
324,1259248,1,1,,144213167,12699,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
325,1259364,1,1,,144213167,12699,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
326,1259365,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
327,1259366,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
328,1259367,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
329,1259368,1,1,,144213167,12699,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
330,1259369,1,1,,144213167,12699,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
331,1259377,1,1,,144213167,12699,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
332,1259378,1,1,,144213167,12699,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
333,1259379,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
334,1259380,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
335,1259381,1,1,,144213167,12699,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
336,1259382,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
337,1259383,1,1,,144213167,12699,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
338,1259384,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
339,1259385,1,1,,144213167,12699,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
340,1259386,1,1,,144213167,12699,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
341,1259387,1,1,,144213167,12699,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
342,1259388,1,1,,144213167,12699,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
343,1259390,1,1,,144213167,12699,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
344,1259391,1,1,,144213167,12699,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
345,1259392,1,1,,144213167,12699,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
346,1259393,1,1,,144213167,12699,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
347,1259394,1,1,,144213167,12699,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
348,1259395,1,1,,144213167,12699,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
349,1259396,1,1,,144213167,12699,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
350,1259401,1,1,,144213167,12699,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
351,1259402,1,1,,144213167,12699,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
352,1259403,1,1,,144213167,12699,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
353,1259404,1,1,,144213167,12699,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
354,1259407,1,1,,363898354,12699,Active,,,,,CCRIS mutagenicity studies,Other,,
355,1259408,1,1,,363895862,12699,Active,,,,,GENE-TOX mutagenicity studies,Other,,
356,1259408,1,1,,363897153,12699,Active,,,,,GENE-TOX mutagenicity studies,Other,,
357,1259411,1,1,,363898354,12699,Active,,,,,CCRIS carcinogenicity studies,Other,,
